Comments
Will the Interim Budget (to be presented on February 1) bolster schemes like the Ayushman Bharat insurance programmes or research-linked tax-sops for the pharmaceutical industry looking to climb the innovation ladder? Industry expectations are low, but it’s never over till the final presentation is made by the Finance Minister.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.